Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder: Symptoms, Quality of Life and Resource Use under Customary Clinical Care

Author： Mahmoud R.A.   Engelhart L.M.   Janagap C.C.   Oster G.   Ollendorf D.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.5, 2004-01, pp. : 275-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison   Caroline M. Perry  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1715-1736

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison   Scott Lesley J.  

CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. : 1027-1052

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Gunasekara N.S.   Spencer C.M.   Keating G.M.  

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1217-1251

Adis International

Access to resources Recommend Favorite

Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

By Rosa Fernanda  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia

By Awad A. George  

CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. : 877-893

Adis International

Access to resources Recommend Favorite